Jul 8, 2026 07:00AM
Jun 25, 2026 07:00AM
Jun 25, 2026 07:00AM
May 12, 2026 07:00AM
Apr 29, 2026 04:05PM
Apr 16, 2026 07:00AM
Apr 15, 2026 04:05PM Glaukos receives permanent J-code for Epioxa keratoconus treatment
Apr 15, 2026 04:05PM
Apr 8, 2026 07:00AM
Apr 6, 2026 07:00AM
Mar 19, 2026 07:00AM
Feb 17, 2026 04:05PM
Jan 28, 2026 09:05AM
Jan 28, 2026 07:01AM Glaukos receives FDA approval for repeat use of iDose TR glaucoma implant
Jan 28, 2026 07:00AM
Jan 20, 2026 07:00AM
Jan 13, 2026 04:06PM
Jan 13, 2026 04:05PM
Dec 16, 2025 07:00AM
Nov 3, 2025 07:00AM
Oct 29, 2025 04:05PM Glaukos Announces Third Quarter 2025 Financial Results
Oct 20, 2025 07:00AM
Oct 20, 2025 07:00AM
Oct 14, 2025 07:00AM
Oct 8, 2025 07:00AM
Sep 25, 2025 04:05PM
Sep 25, 2025 04:05PM
Aug 13, 2025 07:00AM Glaukos Announces Participation in Wells Fargo Healthcare Conference
Jul 30, 2025 04:05PM
Jul 9, 2025 07:00AM
Jun 30, 2025 07:38AM
Jun 25, 2025 04:05PM
Jun 25, 2025 04:05PM
Jun 25, 2025 07:00AM
May 13, 2025 07:00AM Glaukos Announces Participation in Upcoming Investor Conferences
May 1, 2025 07:37AM
Apr 30, 2025 04:05PM
Apr 23, 2025 07:00AM
Apr 16, 2025 07:00AM
Apr 9, 2025 07:00AM
Mar 11, 2025 07:00AM
Feb 24, 2025 07:01AM Glaukos Corporation (GKOS) Announces FDA Acceptance of NDA Submission for Epioxa
Feb 24, 2025 07:00AM
Feb 20, 2025 04:05PM
Jan 23, 2025 07:00AM
Jan 14, 2025 04:06PM
Jan 14, 2025 04:05PM
Dec 23, 2024 07:05AM
Dec 23, 2024 07:00AM Glaukos Submits New Drug Application to U.S. FDA for Epioxa™
Dec 17, 2024 07:00AM

325,687 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All